Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-96.28	16.33	-438.93
Graham Fair Price	39.52	29739.27	21314.96
PEG	-54.32	-0.03	0.06
Price/Book	-1.70	1.18	1.20
Price/Cash Flow	-62.94	-16.55	44.65
Prices/Earnings	-46.22	8.03	-14.94
Price/Sales	-34.73	1.96	3.00
Price/FCF	-62.94	-16.55	44.65
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	3.59	0.50	0.49
Operating Margin	153.75	0.14	-0.05
ROA	73.96	0.01	< 0.005
ROE	-0.02	0.04	82.77
ROIC	-0.01	0.03	132.20
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.17	0.07	160.77
Dividends QOQ	2.38	-1.00	-57.99
EBIT QOQ	-1.45	4.94	241.65
EPS QOQ	-2.45	2.89	17.73
FCF QOQ	-0.81	-3.74	-359.70
Revenue QOQ	-0.23	0.55	139.34
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	240.67	146.45	-39.15
Days Sales Outstanding (DSO)	53.99	64.22	18.95
Inventory Turnover	0.37	0.61	64.34
Debt/Capitalization	0.41	0.45	8.51
Quick Ratio	0.94	1.23	30.35
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	31751.92	32768.76	3.20
Cash	10665.48	10905.52	2.25
Capex	-890.66	-424.37	52.35
Free Cash Flow	850.98	-2329.65	173.76
Revenue	12660.28	19678.95	55.44
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.93	2.09	8.43
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-124.61	5.45	-95.63
Naive Interpretation	Member

06 - Financial Health · Bad

Rating